Analyst Matt Borsch cites “uncertainty regarding November 2020 election outcomes.”
The analyst says HUM and UNH are “more heavily
tied” to Medicare Advantage, which seems to have continued bipartisan
support, but there could be a shift towards less favorable regulation if
President Trump loses re-election.
BMO cuts its HUM target from $345 to $290.
Humana shares are down 0.4% pre-market to $256.50. The company has an Outperform average Sell Side rating.
UnitedHealth are down 0.7% pre-market to $213.70, and UNH also has a bullish average Sell Side rating.
https://seekingalpha.com/news/3502531-humana-unh-downgraded-medicare-advantage-risk
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.